Inhibitors of angiogenesis: ready for prime time?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Baillière's Best Practice & Research : Clinical Rheumatology

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.berh.2014.10.012PMID 25481555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tie2 Signaling Cooperates with TNF to Promote the Pro-Inflammatory Activation of Human Macrophages Independently of Macrophage Functional Phenotype

  2014cited by this paper
• The potential role of angiogenic factors in rheumatoid arthritis

  2014cited by this paper
• NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis

  2014cited by this paper
• An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

  2013cited by this paper
• Norisoboldine Suppresses VEGF-Induced Endothelial Cell Migration via the cAMP-PKA-NF-κB/Notch1 Pathway

  2013cited by this paper
• Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

  2013cited by this paper
• Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α pathway.

  2013cited by this paper
• NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases

  2013cited by this paper
• Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.

  2013cited by this paper
• How to perform and analyse synovial biopsies.

  2013cited by this paper
• Physiology and Pharmacology of Plerixafor

  2013cited by this paper
• Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

  2013cited by this paper
• Small Molecule Inhibitors of CXCR4

  2013cited by this paper
• The role of IL-17-secreting mast cells in inflammatory joint disease

  2013cited by this paper
• Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12

  2013cited by this paper
• Double-antiangiogenic protein DAAP targeting vascular endothelial growth factor A and angiopoietins attenuates collagen-induced arthritis

  2013cited by this paper
• Targeting angiopoietin-2 signaling in cancer therapy

  2013cited by this paper
• Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype

  2012cited by this paper
• Recombinant human endostatin inhibits adjuvant arthritis by down-regulating VEGF expression and suppression of TNF-α, IL-1β production

  2012cited by this paper
• Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis

  2012cited by this paper
• Suppression of endothelial cell activity by inhibition of TNFα

  2012cited by this paper
• Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis

  2012cited by this paper
• Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis

  2012cited by this paper
• Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization

  2011cited by this paper
• Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis.

  2011cited by this paper
• Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors

  2011cited by this paper
• Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis

  2011cited by this paper
• Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-α in Retinopathy and Psoriasis*

  2011cited by this paper
• The pathogenesis of rheumatoid arthritis.

  2011cited by this paper
• Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium

  2011cited by this paper
• Molecular mechanisms and clinical applications of angiogenesis

  2011cited by this paper
• Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

  2011cited by this paper
• Basic and therapeutic aspects of angiogenesis.

  2011cited by this paper
• Targeting the tumour vasculature: insights from physiological angiogenesis

  2010cited by this paper
• Reliability of ultrasonography to detect synovitis in rheumatoid arthritis: A systematic literature review of 35 studies (1,415 patients)

  2010cited by this paper
• Pathogenic role of CXCR7 in rheumatoid arthritis.

  2010cited by this paper
• IL-17 Contributes to Angiogenesis in Rheumatoid Arthritis

  2010cited by this paper
• Mast cells express IL-17A in rheumatoid arthritis synovium.

  2010cited by this paper
• Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis

  2010cited by this paper
• Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue

  2010cited by this paper
• Angiogenesis and its targeting in rheumatoid arthritis.

  2009cited by this paper
• Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice.

  2009cited by this paper
• Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy

  2009cited by this paper
• Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis.

  2009cited by this paper
• Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint

  2009cited by this paper
• How to perform and analyse synovial biopsies.

  2009cited by this paper
• Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats.

  2009cited by this paper
• Vascular Endothelial Growth Factor

  2009cited by this paper
• Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes.

  2008cited by this paper
• Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts

  2008cited by this paper
• Blockage of the formation of new blood vessels by recombinant human endostatin contributes to the regression of rat adjuvant arthritis.

  2007cited by this paper
• Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

  2007cited by this paper
• Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice.

  2007cited by this paper
• Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis

  2007cited by this paper
• The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis.

  2007cited by this paper
• The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.

  2007cited by this paper
• Macrophages and their products in rheumatoid arthritis

  2007cited by this paper
• Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.

  2006cited by this paper
• Reduction of proinflammatory cytokine expression in the synovium by targeting IKKbeta in vivo in a rat model.

  2006cited by this paper
• Cytokines and chemokines as regulators of angiogenesis in health and disease.

  2006cited by this paper
• IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes

  2006cited by this paper
• Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment

  2006cited by this paper
• Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts.

  2006cited by this paper
• Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation

  2006cited by this paper
• Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.

  2006cited by this paper
• Amelioration of Arthritis by Intraarticular Dominant Negative IKKβ Gene Therapy Using Adeno-Associated Virus Type 5

  2006cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.

  2006cited by this paper
• Integrins: Molecular targets in cancer therapy

  2006cited by this paper
• Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction.

  2005cited by this paper
• Inflammation-associated cancer: NF-kappaB is the lynchpin.

  2005cited by this paper
• NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-α monoclonal antibody therapy

  2005cited by this paper
• Angiogenesis in life, disease and medicine

  2005cited by this paper
• Inflammation-associated cancer: NF-κB is the lynchpin

  2005cited by this paper
• Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis

  2005cited by this paper
• Angiogenesis as a therapeutic target

  2005cited by this paper
• Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent

  2004cited by this paper
• Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization

  2004cited by this paper
• Contrast-enhanced dynamic and static MRI correlates with quantitative 99Tcm-labelled nanocolloid scintigraphy. Study of early rheumatoid arthritis patients.

  2004cited by this paper
• T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases.

  2004cited by this paper
• HIF-1alpha is essential for myeloid cell-mediated inflammation.

  2003cited by this paper
• HIF-1 Is Essential for Myeloid Cell-Mediated

  2003cited by this paper
• Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis 1

  2003cited by this paper
• Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

  2003cited by this paper
• Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis.

  2003cited by this paper
• A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice.

  2003cited by this paper
• Regulation of angiogenesis by Th1- and Th2-type cytokines.

  2003cited by this paper
• Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis

  2003cited by this paper
• Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease.

  2003cited by this paper
• Interleukin-17 promotes angiogenesis and tumor growth.

  2003cited by this paper
• Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases

  2002cited by this paper
• VEGF and imaging of vessels in rheumatoid arthritis

  2002cited by this paper
• Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging.

  2002cited by this paper
• Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

  2002cited by this paper
• Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue

  2002cited by this paper
• Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation.

  2001cited by this paper
• Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature

  2001cited by this paper
• Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation

  2001cited by this paper

• Angiotensin-(1-7) Inhibits Angiogenesis and Alleviates Joint Damage in CIA Mice via the Hippo–YAP Pathway

  2025cites this paper
• A Study on the Pharmacological Effects and Mechanism of Rhodojaponin III in Rheumatoid Arthritis.

  2023cites this paper
• Could SCUBE be used as a therapeutic target in rheumatoid arthritis?

  2023cites this paper
• Comparison of Angio PLanewave UltraSensitive and Power Doppler Ultrasound in Detecting Synovial Blood Flow in Wrist and Finger Joints of Rheumatoid Arthritis Patients.

  2023cites this paper
• Exploring the chondroprotective effect of Chaenomeles speciosa on Glucose-6-Phosphate Isomerase model mice using an integrated approach of network pharmacology and experimental validation.

  2023cites this paper
• Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.

  2020cites this paper
• Comprehensive Bioinformatics Analysis Reveals Hub Genes and Inflammation State of Rheumatoid Arthritis

  2020cites this paper
• miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.

  2019cites this paper
• THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PhD) Downstream effects of targeting angiogenesis in the inflamed joint and systemic vasculature in inflammatory arthritis

  2019cites this paper
• Tumor angiogenesis and anti-angiogenic gene therapy for cancer

  2018influential citation
• GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis

  2018cites this paper
• Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic

  2017cites this paper
• Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.

  2017cites this paper
• Targeting non-canonical nuclear factor-&kgr;B signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis

  2017cites this paper
• Coexistence d’une polyarthrite rhumatoïde et d’un syndrome TEMPI : nouveau regard sur les maladies en rapport avec la micro-angiogenèse

  2017cites this paper
• Endothelial cells: From innocent bystanders to active participants in immune responses.

  2017cites this paper
• Targeting synovial neoangiogenesis in rheumatoid arthritis.

  2017cites this paper
• Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic

  2017cites this paper
• The joint synovium: A critical determinant of articular cartilage fate in inflammatory joint diseases.

  2017cites this paper
• Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis

  2017cites this paper
• Rheumatoid Arthritis and Other Inflammatory Articular Diseases

  2017cites this paper
• Etude de l’efficacité des stratégies d’immunothérapies actives anti-cytokine et évaluation des conséquences de la vaccination anti-TNF dans des modèles infectieux

  2016cites this paper
• Physiological Capillary Regression is not Dependent on Reducing VEGF Expression

  2016cites this paper
• Coexistence of rheumatoid arthritis and TEMPI syndrome: New insight in microangiogenic-related diseases.

  2016cites this paper
• Targeting of proangiogenic signalling pathways in chronic inflammation

  2016cites this paper
• Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68

  2016cites this paper
• Successes and failures of chemokine-pathway targeting in rheumatoid arthritis

  2016cites this paper